Legacy Pharmaceutical Packaging LLC is recalling 111,948 bottles of Metformin Hydrochloride Tablets USP (1000 mg), a prescription medication used to treat type 2 diabetes. This recall was initiated because bottles were found to contain foreign tablets or capsules—specifically, Metformin tablets with a different imprint than what should be in the bottle. These products were distributed to Walmart distribution centers in Georgia and Arkansas and were packaged in 60-count bottles.
Taking a foreign or incorrect medication can lead to a lack of proper treatment for your condition or potential side effects from an unknown drug. If the foreign tablet is a different dosage or a different medication entirely, it could cause serious health complications.
Healthcare consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.